tiprankstipranks
Krebs Biochemicals & Industries Ltd. (IN:KREBSBIO)
:KREBSBIO
India Market
KREBSBIO
Krebs Biochemicals & Industries Ltd.
RESEARCH TOOLSreports

Krebs Biochemicals & Industries Ltd. (KREBSBIO) Ratios

0 Followers

Krebs Biochemicals & Industries Ltd. Ratios

IN:KREBSBIO's free cash flow for Q2 2026 was ₹-0.04. For the 2026 fiscal year, IN:KREBSBIO's free cash flow was decreased by ₹ and operating cash flow was ₹-1.06. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 0.09 0.10 0.28 0.33 0.45
Quick Ratio
 0.04 0.04 0.12 0.08 0.12
Cash Ratio
 <0.01 <0.01 <0.01 <0.01 <0.01
Solvency Ratio
 -0.05 -0.06 -0.04 -0.07 -0.14
Operating Cash Flow Ratio
 -0.02 -0.08 0.04 -0.50 -0.22
Short-Term Operating Cash Flow Coverage
 -0.03 -0.15 0.23 -2.44 -1.69
Net Current Asset Value
₹ -3.17B₹ -3.05B₹ -2.80B₹ -2.58B₹ -2.29B
Leverage Ratios
Debt-to-Assets Ratio
 1.33 1.26 1.34 1.05 0.99
Debt-to-Equity Ratio
 -1.38 -1.45 -2.00 -1.84 -2.50
Debt-to-Capital Ratio
 3.65 3.22 2.00 2.19 1.66
Long-Term Debt-to-Capital Ratio
 39.59 10.74 2.85 2.35 2.30
Financial Leverage Ratio
 -1.03 -1.16 -1.49 -1.76 -2.53
Debt Service Coverage Ratio
 -0.15 -0.25 -0.56 -1.16 -2.11
Interest Coverage Ratio
 -2.42 -3.67 -3.31 -7.38 -7.33
Debt to Market Cap
 1.66 1.45 1.39 1.51 0.46
Interest Debt Per Share
 105.86 101.18 112.87 86.36 89.74
Net Debt to EBITDA
 -22.98 -14.81 -28.83 -12.08 -5.73
Profitability Margins
Gross Profit Margin
77.53%87.17%-21.57%46.84%-9.65%
EBIT Margin
-69.74%-48.51%-29.83%-41.66%-65.56%
EBITDA Margin
-41.83%-33.06%-16.41%-29.08%-55.01%
Operating Profit Margin
-71.31%-50.15%-30.72%-42.08%-66.15%
Pretax Profit Margin
-99.23%-62.16%-39.13%-47.36%-74.58%
Net Profit Margin
-99.30%-62.20%-39.13%-47.36%-74.58%
Continuous Operations Profit Margin
-99.30%-62.20%-39.13%-47.36%-74.58%
Net Income Per EBT
100.07%100.06%100.00%100.00%100.00%
EBT Per EBIT
139.17%123.97%127.36%112.55%112.74%
Return on Assets (ROA)
-13.78%-15.94%-11.07%-14.11%-23.46%
Return on Equity (ROE)
14.97%18.42%16.55%24.83%59.30%
Return on Capital Employed (ROCE)
-30.23%-33.15%-13.31%-17.43%-35.34%
Return on Invested Capital (ROIC)
-14.82%-18.65%-12.24%-16.13%-32.40%
Return on Tangible Assets
-13.96%-16.16%-11.23%-14.33%-23.82%
Earnings Yield
-17.15%-18.47%-14.19%-20.27%-14.44%
Efficiency Ratios
Receivables Turnover
 460.46 866.24 10.67 66.21 54.91
Payables Turnover
 0.32 0.31 3.23 1.81 1.73
Inventory Turnover
 0.90 0.92 5.98 2.24 2.53
Fixed Asset Turnover
 0.16 0.30 0.34 0.35 0.41
Asset Turnover
 0.14 0.26 0.28 0.30 0.31
Working Capital Turnover Ratio
 -0.23 -0.63 -1.30 -1.38 -1.72
Cash Conversion Cycle
 -736.56 -795.91 -17.74 -33.00 -60.49
Days of Sales Outstanding
 0.79 0.42 34.22 5.51 6.65
Days of Inventory Outstanding
 406.82 396.26 61.00 162.72 144.20
Days of Payables Outstanding
 1.14K 1.19K 112.96 201.24 211.34
Operating Cycle
 407.62 396.68 95.22 168.24 150.85
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.78 -3.66 1.10 -11.46 -7.99
Free Cash Flow Per Share
 -1.73 -5.31 -3.27 -16.50 -18.89
CapEx Per Share
 0.95 1.65 4.37 5.04 10.91
Free Cash Flow to Operating Cash Flow
 2.22 1.45 -2.98 1.44 2.37
Dividend Paid and CapEx Coverage Ratio
 -0.82 -2.21 0.25 -2.27 -0.73
Capital Expenditure Coverage Ratio
 -0.82 -2.21 0.25 -2.27 -0.73
Operating Cash Flow Coverage Ratio
 >-0.01 -0.04 <0.01 -0.13 -0.09
Operating Cash Flow to Sales Ratio
 -0.07 -0.18 0.05 -0.47 -0.29
Free Cash Flow Yield
-2.80%-7.85%-5.07%-29.21%-13.21%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -5.83 -5.41 -7.05 -4.93 -6.93
Price-to-Sales (P/S) Ratio
 5.79 3.37 2.76 2.34 5.17
Price-to-Book (P/B) Ratio
 -0.83 -1.00 -1.17 -1.22 -4.11
Price-to-Free Cash Flow (P/FCF) Ratio
 -35.77 -12.74 -19.73 -3.42 -7.57
Price-to-Operating Cash Flow Ratio
 -79.58 -18.49 58.80 -4.93 -17.91
Price-to-Earnings Growth (PEG) Ratio
 -0.35 -0.15 0.35 0.11 -0.16
Price-to-Fair Value
 -0.83 -1.00 -1.17 -1.22 -4.11
Enterprise Value Multiple
 -36.83 -24.99 -45.64 -20.11 -15.12
Enterprise Value
 3.55B 3.58B 3.78B 3.05B 4.96B
EV to EBITDA
 -36.83 -24.99 -45.64 -20.11 -15.12
EV to Sales
 15.40 8.26 7.49 5.85 8.32
EV to Free Cash Flow
 -95.15 -31.25 -53.56 -8.57 -12.19
EV to Operating Cash Flow
 -211.66 -45.36 159.67 -12.34 -28.84
Tangible Book Value Per Share
 -75.60 -68.91 -56.45 -47.38 -36.16
Shareholders’ Equity Per Share
 -74.59 -67.84 -55.29 -46.13 -34.83
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 0.00 0.00 0.00
Revenue Per Share
 10.68 20.09 23.39 24.18 27.69
Net Income Per Share
 -10.60 -12.50 -9.15 -11.45 -20.65
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.42 1.28 1.31 1.14 1.14
Research & Development to Revenue
 0.07 0.04 0.00 0.00 0.03
SG&A to Revenue
 0.51 0.38 0.01 0.02 0.02
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.05 0.29 -0.12 1.00 0.39
Currency in INR